5-amino-1mq nnmt inhibitor study Reduced calorie diet combined with inhibition establishes a distinct microbiome in DIO mice 5-Amino-1MQ NNMT Inhibitor for Research

The peptide does not stimulate the tissue growth pathways that cause joint and tendon issues

No Human Adverse-Event Programme Without a controlled clinical development programme, the frequency and severity of possible adverse reactions cannot be estimated reliably

That is the evidence gap, stated plainly: the mechanism is well-motivated and the preclinical signal is consistent, but no human study has confirmed that any of it translates to people, at any dose, by any route

Second, the doses are small because the target is a high-affinity intracellular enzyme, not a receptor that needs saturating with milligrams of drug